These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20597034)

  • 1. [The costs of depression and the cost-effectiveness of treatment].
    König HH; Luppa M; Riedel-Heller S
    Psychiatr Prax; 2010 Jul; 37(5):213-5. PubMed ID: 20597034
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
    Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
    Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of psychological treatment.
    Moscarelli M; Rupp A
    J Ment Health Policy Econ; 2008 Mar; 11(1):1-2. PubMed ID: 18540131
    [No Abstract]   [Full Text] [Related]  

  • 6. The costs of depression: direct and indirect; treatment versus nontreatment.
    Panzarino PJ
    J Clin Psychiatry; 1998; 59 Suppl 20():11-4. PubMed ID: 9881536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-Effectiveness of the Treatment of Depression in Old Age].
    Bock JO; Brettschneider C; Wegener A; Riedel-Heller S; König HH
    Psychiatr Prax; 2015 Jul; 42(5):240-7. PubMed ID: 26101862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [At what time is a reduction of medical under- or overtreatment sensible? Treatment of acute depression as an example].
    Gandjour A; Lauterbach KW
    Psychiatr Prax; 2004 Apr; 31(3):157-62. PubMed ID: 15042479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability from depression: the public health challenge to primary care.
    Rost K
    Nord J Psychiatry; 2009; 63(1):17-21. PubMed ID: 19023696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health economic aspects of medical care and therapeutic options for schizophrenic and depressive patients in Germany].
    Heuser I; Dettling M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Aug; 47(8):745-50. PubMed ID: 15340717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of depression in Sweden from 1997 to 2005.
    Sobocki P; Lekander I; Borgström F; Ström O; Runeson B
    Eur Psychiatry; 2007 Apr; 22(3):146-52. PubMed ID: 17194573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The concept of depression].
    Scotto JC
    Encephale; 1996 May; 22 Spec No 1():1-2. PubMed ID: 8767021
    [No Abstract]   [Full Text] [Related]  

  • 14. Are psychological treatments for depression in primary care cost-effective?
    Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
    J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term health insurance payments for depression in Germany - a secondary analysis of routine data].
    Stamm K; Reinhard I; Salize HJ
    Neuropsychiatr; 2010; 24(2):99-107. PubMed ID: 20605005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
    Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
    Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
    Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
    J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the importance of care for the mentally ill and options for legal health care insurance].
    Liecker B; Hecke T; Müller H
    Psychiatr Prax; 2005 Apr; 32(3):151-3. PubMed ID: 15818522
    [No Abstract]   [Full Text] [Related]  

  • 19. The costs associated with antidepressant use in depression and anxiety in community-living older adults.
    Vasiliadis HM; Latimer E; Dionne PA; Préville M
    Can J Psychiatry; 2013 Apr; 58(4):201-9. PubMed ID: 23547643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and change in the prescribing of anti-depressants in New Zealand: 1993-1997.
    Roberts E; Norris P
    N Z Med J; 2001 Feb; 114(1125):25-7. PubMed ID: 11277470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.